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ABSTRACT 
Phytoestrogens act as agonists in bone formation and differentiation which not only 
improves the osteoblast formation, but also affects the bone metabolism, in general. 
Strong bones depend on the ability of osteoblasts to mineralize the newly formed 
tissue and osteoclasts in removing damaged and dysfunctional bone tissue. Loss of 
mineralization leads to a weak bone structure and increase fracture risk. Bisphenol A 
(BPA), a known xenoestrogen, disturbs the osteoblast proliferation, differentiation and 
mineralization via changes in receptor activator of nuclear factor kappa B ligand 
(RANKL) and osteoprotegerin (OPG) expression and associated with binding to the 
non-classical oestrogen related receptor gamma (ERRG). However, the effect of 
phytoestrogens against the deteriorative effect of BPA related to the bone health is not 
yet addressed, to date. The present study was aimed to investigate the potential 
protective effects of soy phytoestrogens on BPA-exposed osteoblast-like cells, hFOB 
1.19 cells. Following 24h of incubation with 12.5 ug/mL of BPA, the cells were 
treated with daidzein (Dz), genistein (Gt) and equol (Eq) at different concentrations 
for 24h. The important bone biomarkers; RANKL, OPG and low-density lipoprotein 
receptor-5 (LRP-5) along with inflammatory biomarkers and transcription factors 
were analysed. Cell mineralization capacity of phytoestrogens was investigated by 
evaluating calcium, phosphate contents and alkaline phosphatase activity. Bone 
related markers; osteocalcin and osteonectin, responsible in maintaining 
mineralization were also measured. Cells incubated with BPA 12.5 [ig/mL alone 
showed a decrease in bone formation and bone mineralization. Following treatment 
with phytoestrogens, there was increased cell viability in BPA induced hFOB 1.19 
cells. The suppression of RANKL and expression of OPG and LRP-5 levels in 
phytoestrogens-treated cells were observed. There was a decrease in IL-6 and TNF-a; 
increase in osterix (Osx) and Runt-related transcription factor 2 (RUNX2) expression 
following phytoestrogens treatment. The enhanced mineralization efficacy of Dz and 
Gt (particularly at a dose of 5 and 40 (j,g/mL, respectively) was evidenced by 
increasing calcium and phosphate content with higher ALP activity, compared to the 
untreated BPA group. Osteocalcin and osteonectin levels were increased. It was 
observed that the protein expression of ERRG was high in the untreated groups 
whereas ER alpha (ERa) and beta (ERP) were relatively increased with 
phytoestrogens treatment under BPA exposure. There was upregulation of MAPK3 
and GPR30 expressions which are responsible for osteoblast differentiation. The 
present findings indicate that phytoestrogens directly improve the osteoblast formation 
via RANKL/OPG pathway and revert the demineralization process in hFOB 1.19 cells 
by significantly downregulating the ERRG and upregulating the ERa and ERP 
receptors under BPA exposure. The synergistic effects are observed in ESR1 and 
ESR2 activations. Treatment with phytoestrogens (specifically, low dose of Dz and 
high dose of Gt) significantly revert the deteriorative effect of BPA on hFOB 1.19 
cells. 
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